Application no. and date | 19208570.2 (espacenet) (Federated) (European Patent Register), 20090625 | Patent/reg. no. and date | DK/EP 3628686, 20210721 | Publication date | 20200401 | Priority no. and date | US 75697 P, 20080625, US 7569208 P, 20080625, US 155041 P, 20090224, US 15510509 P, 20090224, CH 8322009, 20090602 | EP pub. no. and date |
EP 3628686 20200401 | Effective date | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | Applicant ref. no. | V344802DK00 | Inventor | BORRAS, Leonardo, Bundentalstrasse 1
8952 Schlieren, CH, Urech, David, Sonnenblickstrasse 8
8645 Jona, CH | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 47/68 (2017.01) , A61P 37/02 (2006.01) , A61P 37/06 (2006.01) , C07K 16/22 (2006.01) , C07K 16/24 (2006.01) | Title | Humanisering af kanin-antistoffer under anvendelse af et universelt antistof-framework | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|